EDWARDS LIFESCIENCES EDWARDS INTUITY ELITE VALVE SYSTEM; HEART-VALVE, NON-ALLOGRAFT TISSUE
|
Back to Search Results |
|
Model Number 8300AB |
Device Problems
Fluid/Blood Leak (1250); Gradient Increase (1270); Insufficient Information (3190)
|
Patient Problems
Heart Failure/Congestive Heart Failure (4446); Insufficient Information (4580)
|
Event Date 11/10/2023 |
Event Type
Injury
|
Event Description
|
Through implant patient registry it was learned a 23mm 8300ab aortic valve was explanted after an implant duration of six (6) years, due to unknown reasons.Per idc, explant was due to deficiency of the original device.The explanted device was replaced with a 23mm 11500a aortic valve.Patient post-operative status noted as in recovery.Edwards lifesciences maintains an implant patient registry.This registry is a patient tracking mechanism for serialized edwards implantable devices (bioprosthetic heart valves and annuloplasty rings), rather than a true post-market surveillance registry.Through the registry, edwards is notified when these devices are implanted.In addition, patient and/or device status may be reported to the registry via the implantation data cards.The information is received from various sources (e.G.Surgeon, hospital, and patient family members) and is not received in the form of a conventional customer complaint.The information reported may or may not be related to the edwards device.
|
|
Manufacturer Narrative
|
The device was not returned to edwards for evaluation as it was reported to not be available.Attempts to retrieve additional information is in process.The investigation is still in progress; therefore, a conclusion has yet to be established.A supplemental report will be submitted accordingly upon investigation completion.Edwards will continue to review and monitor all events.Trends are monitored on a monthly basis and if action is required, appropriate investigation will be performed.
|
|
Event Description
|
Through implant patient registry and investigation, it was learned a 23mm 8300ab aortic valve was explanted after an implant duration of six (6) years, due to aortic valve insufficiency and stenosis.The explanted device was then replaced with a 23mm 11500a aortic valve.Per medical records patient presented with acute systolic chf and underwent redo avr and mvr for regurgitation with insertion of iabp.On pod #24, the patient was discharged to a skilled nursing facility.
|
|
Manufacturer Narrative
|
The device history record was reviewed and shows that this device met all manufacturing specifications for product release prior to distribution.No issues were identified that would have impacted this event.Stenosis, which develops progressively over time, can be due to a number of issues.Additionally, there can be a number of potential known and unknown patient-related contributing factors.Structural valve deterioration (svd) is the most common reason for bioprosthesis explant and encompasses multiple failure modes, including calcification, noncalcific degeneration, dehiscence, cusp thickening or fibrosis, or a combination of these.Such failure modes, occurring singularly or concomitantly, may contribute to stenosis and/or regurgitation.Alternatively, non-structural valve dysfunction (nsvd) may also play a role in the development of valvular stenosis.Stenosis is most commonly related to patient factors and is not usually an indication of a device malfunction related to a manufacturing deficiency.The most likely cause is patient factors, including a history of stage 3 chronic kidney disease (ckd) and coronary artery disease (cad).
|
|
Search Alerts/Recalls
|
|
|